Details for New Drug Application (NDA): 087547
✉ Email this page to a colleague
NDA 087547 describes ISOPTO CETAPRED, which is a drug marketed by Alcon and is included in one NDA. Additional details are available on the ISOPTO CETAPRED profile page.
The generic ingredient in ISOPTO CETAPRED is prednisolone acetate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
The generic ingredient in ISOPTO CETAPRED is prednisolone acetate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
Summary for 087547
| Tradename: | ISOPTO CETAPRED |
| Applicant: | Alcon |
| Ingredient: | prednisolone acetate; sulfacetamide sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;OPHTHALMIC | Strength | 0.25%;10% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
